| Fady Wahba, RPH | |
|
3171 Balfour Rd, Brentwood, CA 94513-2962 | |
| (925) 626-3776 | |
| Not Available |
| Full Name | Fady Wahba |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3171 Balfour Rd, Brentwood, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114660222 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 86031 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Fady Wahba, RPH 3171 Balfour Rd, Brentwood, CA 94513-2962 Ph: () - | Fady Wahba, RPH 3171 Balfour Rd, Brentwood, CA 94513-2962 Ph: (925) 626-3776 |
News Archive
Pancreatic cancer is lethal in about 95% of cases mostly due to failure of first-line therapy gemcitabine. AntiCancer Inc.'s oral methioninase (AC 00619), which is in late pre-clinical development as an anti-cancer as well as an anti-aging drug, has now been shown to overcome gemcitabine resistance in mouse models of human pancreatic cancer, including AntiCancer's patient-derived orthotopic xenograft mouse models.
CROs and Pharmaceutical companies are speeding the process of study launch and accelerating patient recruitment. Such initiatives involve the adoption of new processes, technologies and organisational structure. One such initiative is MediciGlobal's unique and proprietary web-based system called ADapt, focused on launching patient recruitment programmes faster.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
John Theurer Cancer Center at Hackensack University Medical Center will host a hematological malignancies conference for physicians and patients on Friday, April 23 and Saturday, April 24. The event, entitled "Current and Innovative Modalities in the Management of Hematological Malignancies", is part of John Theurer Cancer Center's commitment to provide both healthcare professionals as well as patients with an update on the newest advances in the field of blood-borne cancers.
› Verified 1 days ago
Clive Lin, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2400 Sand Creek Rd, Brentwood, CA 94513 Phone: 925-513-8844 | |
Grace Lan, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3110 Balfour Rd, Brentwood, CA 94513 Phone: 925-626-6030 | |
Veronia Hanna, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3110 Balfour Rd, Brentwood, CA 94513 Phone: 925-626-6020 | |
Dr. Chimai Thi Cao-luu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3171 Balfour Rd, Brentwood, CA 94513 Phone: 925-626-3963 | |
Phuong Huynh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6570 Lone Tree Way, Brentwood, CA 94513 Phone: 925-240-6043 Fax: 925-240-6134 | |
Alejandro Guan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2643 Presidio Dr, Brentwood, CA 94513 Phone: 925-481-4921 |